ADENOSINE and OFF LABEL USE

Overview

OFF LABEL USE is the #2 most commonly reported adverse reaction for ADENOSINE, manufactured by Dalim Tissen. There are 98 FDA adverse event reports linking ADENOSINE to OFF LABEL USE. This represents approximately 3.0% of all 3,219 adverse event reports for this drug.

Patients taking ADENOSINE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OFF LABEL USE is a less commonly reported adverse event for ADENOSINE, but still significant enough to appear in the safety profile.

Other Side Effects of ADENOSINE

In addition to off label use, the following adverse reactions have been reported for ADENOSINE:

• DRUG INEFFECTIVE — 327 reports
• SUPRAVENTRICULAR TACHYCARDIA — 94 reports
• HYPOTENSION — 86 reports
• CARDIAC ARREST — 78 reports
• DYSPNOEA — 74 reports
• PAIN — 67 reports
• ATRIAL FIBRILLATION — 64 reports
• BRADYCARDIA — 63 reports
• TACHYCARDIA — 61 reports
• ANXIETY — 55 reports

Other Drugs Associated with OFF LABEL USE

The following drugs have also been linked to off label use in FDA adverse event reports:

Does ADENOSINE cause OFF LABEL USE?

OFF LABEL USE has been reported as an adverse event in 98 FDA reports for ADENOSINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OFF LABEL USE with ADENOSINE?

OFF LABEL USE accounts for approximately 3.0% of all adverse event reports for ADENOSINE, making it one of the most commonly reported side effect.

What should I do if I experience OFF LABEL USE while taking ADENOSINE?

If you experience off label use while taking ADENOSINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages